Sapient offers discovery services to biopharma, non-profit, and academic organizations. Their biomarker discovery platform uses next-generation mass spectrometry technologies and advanced biocomputational/statistical approaches to rapidly identify, validate, and translate small molecule biomarkers of biological processes, disease mechanisms, and drug responsiveness across all drug development phases.